FDA Lists Benefits And Risks Of Surgical Mesh For Hernia Repair
The Food and Drug Administration is providing patients with information on the pros and cons of hernia mesh surgery, a procedure that has come under intense scrutiny in recent years.
You may also be interested in...
The US FDA is reminding the public that there are no surgical mesh products that have been cleared or approved by the agency for use in breast surgery.
The US FDA says final data from two Boston Scientific postmarket studies have reinforced the agency’s position that the company’s transvaginal mesh to treat pelvic organ prolapse (POP) has a poor benefit-risk profile. The firm’s mesh has been off the US market since 2019.
The settlement puts to rest product liability and patient safety suits in 47 states and the District of Columbia.